Nuvalent, Inc.
Board Member
2025-06-18–2026-07-15
Anna Protopapas
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anna Protopapas
Earlier roles on record: Board Member at Nuvalent, Inc. until July 15, 2026. Nuvalent, Inc. reported in an 8-K filed July 15, 2026 that Anna Protopapas resigned as director, effective July 15, 2026.
“In accordance with the Merger Agreement, at the Effective Time, each of the directors of the Company (James R. Porter, Ph.D.; Grant C. Bogle; Michael L. Meyers, M.D., Ph.D.; Christy Oliger; Anna Protopapas; Ron Squarer; Sapna Srivastava, Ph.D.; and Cameron A. Wheeler, Ph.D.) resigned from his or her respective position as a member of the Company's board of directors, and any committee thereof.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Nuvalent, Inc.
Board Member
SEC 8-K
2025-06-18–2026-07-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.